CorMedix Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 03/30/23
Cormedix Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update on March 30, 2023GlobeNewsWire • 03/21/23
Cormedix Inc. Announces Presentation at Conference Showing Mortality Risk and Complications in Patients Experiencing Catheter Related Blood Stream InfectionsGlobeNewsWire • 12/06/22
CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 11/10/22
CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10GlobeNewsWire • 11/02/22
CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology ConferenceGlobeNewsWire • 10/20/22
CorMedix Inc. (CRMD) CEO Joseph Todisco on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/11/22
CorMedix Inc. (CRMD) CEO Joe Todisco on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/13/22
CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 05/12/22
CorMedix Inc. to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12GlobeNewsWire • 05/03/22
CorMedix Inc. Announces Scientific Advisory Board to Support Commercialization and Pipeline DevelopmentGlobeNewsWire • 04/07/22
CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/04/22
CorMedix Inc. (CRMD) CEO Matt David on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/30/22
CorMedix Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 03/29/22